Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Single stage treatment of diabetic calcaneal osteomyelitis with an absorbable gentamicin-loaded calcium sulphate/hydroxyapatite biocomposite: The Silo technique..
Foot (Edinb). 34, 40-44.
(2018). A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice..
Blood. 131(21), e1-e11.
(2018). The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study..
J Hypertens. 36(8), 1705-1711.
(2018). Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead..
Metabolism. 78, A4-A9.
(2018). Sleep apnea syndrome, inflammation and oxidative stress in hemodialysis patients..
Hemodial Int. 22(2), 209-216.
(2018). Sleep disorders and health-related quality of life in patients with interstitial lung disease..
Sleep Breath. 22(2), 393-400.
(2018). Small bowel obstruction as a result of an obturator hernia: a rare cause and a challenging diagnosis..
J Surg Case Rep. 2018(7), rjy161.
(2018). Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology..
Int J Cardiol. 258, 1-6.
(2018). Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort..
Cogn Neuropsychiatry. 23(2), 103-115.
(2018). Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke..
Cardiovasc Hematol Disord Drug Targets. 18(2), 134-138.
(2018). Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice..
Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.
(2018). Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
(2018). Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease..
Cardiovasc Hematol Disord Drug Targets. 18(2), 120-126.
(2018). Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
(2018). The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension..
Ann Intern Med. 168(10), 755.
(2018). Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema.
Clinical Genetics. 2612411251726(21367112),
(2018). Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema..
Clin Genet. 94(1), 179-181.
(2018). Sports Behavior in Middle-Aged Individuals with Anomalous Coronary Artery from the Opposite Sinus of Valsalva..
Cardiology. 139(4), 222-230.
(2018). Statistical learning of multisensory regularities is enhanced in musicians: An MEG study..
Neuroimage. 175, 150-160.
(2018). Stroke Incidence and Outcomes in Northeastern Greece: The Evros Stroke Registry..
Stroke. 49(2), 288-295.
(2018). The structural basis of semantic control: Evidence from individual differences in cortical thickness..
Neuroimage. 181, 480-489.
(2018). Structure, function, and responses to injury.
MacSween's pathology of the liver.
(2018). Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?.
J Hypertens. 36(3), 701.
(2018).
(2018).
(2018).